Predictors of Intravenous Immunoglobulin (IVIG) Resistance in Children with Kawasaki Disease in Calabria Region, Italy
1. Predictors of Intravenous Immunoglobulin (IVIG) Resistance in Children with Kawasaki Disease in Calabria Region, Italy

Valentina Talarico; Sara Rizzo; Maria Cirillo; Paola Chiarello; Roberta Bianchi; Roberto Miniero; Maria Concetta Galati; Giuseppe Raiola

Volume 7, Issue 2 , February 2019, , Pages 9027-9036

http://dx.doi.org/10.22038/ijp.2018.34895.3074

Abstract
  Background Kawasaki disease (KD) is the second most common childhood vasculitis and one of the main causes of acquired heart disease in children. Recent work focuses on the early diagnostic ...  Read More
Clinical Pharmacology of the Antimalarial Artemisinin-Based Combination and other Artemisinins in Children
2. Clinical Pharmacology of the Antimalarial Artemisinin-Based Combination and other Artemisinins in Children

Gian Maria Pacifici

Volume 6, Issue 7 , July 2018, , Pages 7901-7928

http://dx.doi.org/10.22038/ijp.2018.31405.2776

Abstract
  In 2010, there were estimated 219 million cases of malaria resulting in 666,000 deaths and two-thirds were children. Children are more vulnerable than adults to malaria parasites. In ...  Read More
Clinical Pharmacology of the Antimalarial Chloroquine in Children and Their Mothers
3. Clinical Pharmacology of the Antimalarial Chloroquine in Children and Their Mothers

Gian Maria Pacifici

Volume 6, Issue 6 , June 2018, , Pages 7733-7758

http://dx.doi.org/10.22038/ijp.2018.30912.2727

Abstract
  Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, and Plasmodium knowlesi are the parasites that infect humans. Plasmodium falciparum and Plasmodium vivax ...  Read More
Treatment of Malaria Parasitaemia in Infants and their Mothers
4. Treatment of Malaria Parasitaemia in Infants and their Mothers

Gian Maria Pacifici

Volume 6, Issue 3 , March 2018, , Pages 7311-7343

http://dx.doi.org/10.22038/ijp.2018.29670.2607

Abstract
  Malaria is an infection sustained by three parasites namely: Plasmodium falciparum, Plasmodium vivax, and Plasmodium ovale. Plasmodium falciparum is the most common and virulent parasite. ...  Read More
Clinical Pharmacology of Ampicillin in Neonates and Infants: Effects and Pharmacokinetics
5. Clinical Pharmacology of Ampicillin in Neonates and Infants: Effects and Pharmacokinetics

Gian Maria Pacifici

Volume 5, Issue 12 , December 2017, , Pages 6383-6410

http://dx.doi.org/10.22038/ijp.2017.26942.2320

Abstract
  Ampicillin is a bactericidal antibiotic, it penetrates into the bacterial wall better than penicillin G and is active against gram-negative bacteria that are resistant to penicillin ...  Read More
Clinical Pharmacology of Cefotaxime in Neonates and Infants: Effects and Pharmacokinetics
6. Clinical Pharmacology of Cefotaxime in Neonates and Infants: Effects and Pharmacokinetics

Gianmaria Pacifici; Giovanna Marchini

Volume 5, Issue 11 , November 2017, , Pages 6111-6138

http://dx.doi.org/10.22038/ijp.2017.26241.2244

Abstract
  Cefotaxime is a bactericidal "third generation" cephalosporin has a broad-spectrum activity against gram-positive microorganisms and exceptional activity against most gram-negative ...  Read More
Clinical Pharmacology of Ciprofloxacin in Neonates: Effects and Pharmacokinetics
7. Clinical Pharmacology of Ciprofloxacin in Neonates: Effects and Pharmacokinetics

Gian Maria Pacifici; Giovanna Marchini

Volume 5, Issue 6 , June 2017, , Pages 5023-5041

http://dx.doi.org/10.22038/ijp.2017.23193.1952

Abstract
  Ciprofloxacin is the most commonly used fluoroquinolone. Ciprofloxacin is prescribed for 1 in 44 Americans. Ciprofloxacin is a broad-spectrum bactericidal antibiotic, effective against ...  Read More
Clinical Pharmacology of Cefepime in Infants and Children
8. Clinical Pharmacology of Cefepime in Infants and Children

Gian Maria Pacifici; Giovanna Marchini

Volume 5, Issue 4 , April 2017, , Pages 4723-4740

http://dx.doi.org/10.22038/ijp.2017.22763.1907

Abstract
  Cefepime is a fourth-generation cephalosporin which is approved in Europe and in the USA. Food and Drug Administration (FDA) approves cefepime in the treatment of febrile neutropenia. ...  Read More
Clinical Pharmacokinetics of Gentamicin in Neonates
9. Clinical Pharmacokinetics of Gentamicin in Neonates

Gian Maria Pacifici; Gian Maria Pacifici

Volume 5, Issue 3 , March 2017, , Pages 4575-4599

http://dx.doi.org/10.22038/ijp.2017.22354.1869

Abstract
  Gentamicin is a bactericidal aminoglycoside antibiotic, it inhibits the protein synthesis. Gentamicin is active against the majority of aerobic gram-negative bacilli such as Pseudomonas, ...  Read More